Insights on the 3D Bioprinters Global Market to 2030 - Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts

DUBLIN, Feb. 2, 2023 /PRNewswire/ -- The "3D Bioprinters Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" report has been added to  ResearchAndMarkets.com's offering.

This report on global 3D Bioprinters Market studies various technologies used for specific applications in the field of healthcare. bioprinters helps to replicate human organs and long term goal is to create a whole organ with this technology. However, this technology is in its rudimentary stage and as the system in developing stage it is slowly being accepted in the mainstream medical field.

For the purpose of this study, the various technology segments studied include syringe based 3D bioprinters, laser based 3D bioprinters, magnetic levitation 3D bioprinters, inkjet based 3D bioprinters and valve-based 3D bioprinters. Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective CAGRs for the period 2022 to 2030, considering 2021 as the base year.

On terms of application type, the global 3D printers market is studied to understand the market maturity and distribution of the market shares. The application segment is further categorized into tissue and organ generation, pharmaceuticals, prosthetics and implants, biosensors and others (food and animal products & personal product testing).

Market size and forecast for these segments during 2020 to 2030 and their compounded annual growth rates for the period 2022 to 2030 are provided in this report. The geographic segmentation of the global 3D bioprinters market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Key Questions Answered in this Report

• What are the key micro and macro environmental factors that are impacting the growth of 3D Bioprinters market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2030.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the 3D Bioprinters market?
• Which is the largest regional market for 3D Bioprinters market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving 3D Bioprinters market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the 3D Bioprinters market worldwide?

Key Topics Covered:

1. Preface

2. Executive Summary

3. 3D Bioprinters Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global 3D Bioprinters Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter's Five Force Model
3.7. PESTEL Analysis

4. 3D Bioprinters Market: By Technology, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Syringe Based 3D Bioprinters
4.3.2. Laser Based 3D Bioprinters
4.3.3. Magnetic Levitation 3D Bioprinters
4.3.4. Inkjet-Based 3D Bioprinters
4.3.5. Valve-Based 3D Bioprinters

5. 3D Bioprinters Market: By Application, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Tissue and Organ Generation
5.3.2. Pharmaceuticals
5.3.3. Prosthetics and Implants
5.3.4. Biosensors
5.3.5. Others (Food and Animal Products Manufacturing and Personal Product Testing)

6. North America 3D Bioprinters Market, 2020-2030, USD (Million)

7. UK and European Union 3D Bioprinters Market, 2020-2030, USD (Million)

8. Asia Pacific 3D Bioprinters Market, 2020-2030, USD (Million)

9. Latin America 3D Bioprinters Market, 2020-2030, USD (Million)

10. Middle East and Africa 3D Bioprinters Market, 2020-2030, USD (Million)

11. Company Profile
11.1. BioBots, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. TeVido BioDevices, LLC
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. 3D Dynamic Systems Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Rokit, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Aspect Biosystems Ltd.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Cyfuse Biomedical K.K.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Organovo Holdings, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Stratasys Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. 3D Systems, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Envision TEC
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Other Notable Market Players
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/xr72jy-bioprinters?w=5

Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Logo- https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets